SMS Pharmaceuticals Limited — Updates, 10-11-2025: Press Release
10-11-2025 | 06:41 pm
10-11-2025 | 06:41 pm
SMS Pharma announced financial results for the quarter and half-year. PAT surged 80% to ₹25.32 Cr, with revenue up 23% to ₹242.43 Cr. Backward integration drove margin expansion. A ₹280 Cr capex is on track, targeting 20% revenue growth and 20% EBITDA margins in FY26.
No comments yet. Be the first to comment!
